Arantxa Eraso

The landscape of definitive radiotherapy discontinuation: a 5-year institutional audit and clinical profiling

Javier González-Viguera, María Belén Núñez, Joël Martinez, Xavier Martin et autres

PURPOSE: Definitive radiotherapy discontinuation is a critical key performance indicator (KPI) in oncological care. This study aimed to determine the frequency of definitive radiotherapy discontinuation and to characterise the clinical profile of a cohort treated between 2020 and 2024. MATERIALS AND METHODS: …

es (code pays fourni par la source)

Cardiac Radiation Dose and Subclinical Coronary Artery Disease Progression after Breast Cancer Radiotherapy: 2-year Cardiac CT Results from the EARLY-HEART Study

Elie Mousseaux, Damian Craiem, Rozemarijn Vliegenthart, Sophie Jacob et autres

Two years after breast cancer radiotherapy, cardiac CT demonstrated dose-associated progression of coronary artery calcification, particularly in the presence of preexisting calcification, while coronary stenosis progression was unrelated to radiation dose.

fr, ar, nl, es, pt, de (code pays fourni par la source)

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

Shelley Potter, KERRY N. L. AVERY, Rosina Ahmed, Jana de Boniface et autres

Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting …

gb, in, se, ch, at, us, jp, il, nl, kr, Éthiopie, be, gr, it, au, br, Égypte, es, ru, ar, tr, pk, de, ca, th, ro, mt, hr, uy, cn, hk, cy, pt (code pays fourni par la source)

P2.08.49 Effect of the Immunological Circadian Rhythm on Treatment of Locally Advanced Non-Small Cell Cancer With Immunotherapy

E. Oliva-Poch, Èlia Sais, María Belén Núñez, Anabel Mañes et autres

es (code pays fourni par la source)

Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d’Oncologia Breast Cancer Observational Cohort Study

Helena Pla, Bartomeu Fullana, Anna Esteve, Roser Fort‐Culillas et autres

Background/Objectives: Few large cohorts with relatively uniform treatment approaches and long-term follow-up are available for assessing clinical outcomes for breast cancer (BC) patients. The Institut Català d’Oncologia (ICO) Breast Cancer Cohort was designed to well characterize treatment patterns and overall survival outcomes …

es (code pays fourni par la source)

Cardiac MRI–based Subclinical Cardiac Dysfunction during 2 Years after Breast Cancer Irradiation: The MEDIRAD EARLY-HEART Study

Jérôme Lamy, Daan S. Spoor, Johannes Albertus Langendijk, Rozemarijn Vliegenthart et autres

Higher cardiac radiation doses in participants with breast cancer treated with radiation therapy after lumpectomy were associated with increased risk of reduced left ventricular global longitudinal strain at 2-year follow-up cardiac MRI.

fr, nl, es, pt (code pays fourni par la source)

Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain

Julieta Corral, Manuel Algara, Carles Muñoz‐Montplet, Arantxa Eraso et autres

Background and purpose: The aim was to estimate the cost of the external beam radiotherapy (EBRT) in public health care centers in Catalonia (Spain), according to the ESTRO-HERO costing model for 2018. Materials and methods: Personnel, equipment, and activity data from 2018 …

es, be (code pays fourni par la source)

1062P Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy

Èlia Sais, A. Plujà, E. Bujons, Felipe Pineda et autres

es (code pays fourni par la source)

2959: The Impact of Advanced Algorithms on the Treatment of Meningiomas

Carles Muñoz‐Montplet, Diego Jurado‐Bruggeman, Arantxa Eraso, Rafael Fuentes‐Raspall

Cardiac Magnetic Resonance-assessed Subclinical Cardiac Dysfunction During 2 Years After Breast Cancer Irradiation: The Medirad-early Heart Study

Jérôme Lamy, Daan S. Spoor, Johannes Albertus Langendijk, Rozemarijn Vliegenhart et autres

fr, nl, es, pt (code pays fourni par la source)

Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes

Javier Sanz, Arantxa Eraso, Reyes Ibáñez, Rachel M. Williams et autres

Conservative surgery is the preferred treatment in the management of breast cancer followed by adjuvant whole-breast irradiation. Since the tumor bed is the main site of relapse, boost doses are conveniently administered according to risk factors for local relapse to increase the …

es, us (code pays fourni par la source)

Un hito en el tratamiento del cáncer de mama: el primer consenso de expertos en España sobre la radioterapia intraoperatoria

Arantxa Eraso